DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Whiteside TL.
FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity.
Expert Opin Ther Targets 2018;
22 (04) 353-363
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.